Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Urogenital Neoplasms × temsirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 3 Neoplasm Metastasis 2 Kidney Neoplasms 2 Urogenital Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdomyosarcoma 1 PRETEXT I Hepatoblastoma 1 Lymphoma, Mantle-Cell 1 Breast Neoplasms 1

Interventions

padeliporfin 2 valrubicin 1 temsirolimus 1 palladium-bacteriopheophorbide 1 abiraterone 1 abemaciclib 1 Tadalafil 1 Standard of Care 1 Prednisone 1 Prednisolone 1 Phosphodiesterase 5 Inhibitors 1 Drug Therapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00631371 2016-04-27

INTORACT

Pfizer

Phase 3 Completed

791 enrolled 11 charts

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡